Dear Readers,
The I-GENE team is pleased to welcome you to the 9th issue of the I-GENE newsletter.
I am proud to say that the team realized some major achievements during the last months. We have optimized the chemistry of our nanoformulation in terms of stability and ability to spontaneously cross the membranes of human melanoma cells to edit them.
Our proprietary formulation was patented on August 28 to protect the
project IPR. We have also launched the I-GeneMatcher software, please, try this free online tool!
Please, stay up to date on the I-GENE project by reading this and the next project newsletters!